SPRIM Global Investments, a Singapore-based health sciences venture capital firm, has led the $21-million equity and debt financing in Australian biotech company Prota Therapeutics, according to an announcement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
